Department of Cardiology, Tokyo Medical University, Tokyo, Japan.
Respiration. 2009;78(3):278-84. doi: 10.1159/000202980. Epub 2009 Feb 16.
Although obstructive sleep apnea (OSA) severity is evaluated by the apnea-hypopnea index (AHI), the value of AHI in evaluating cardiovascular risks, especially in mild to moderate OSA, is unclear.
The purpose of this study is to evaluate the validity of a new index, the integrated area of desaturation (IAD), to detect the incidence of cardiovascular events (CVEs) in such patients.
We enrolled 230 consecutive patients with mild to moderate OSA and 354 with severe OSA diagnosed by polysomnography, of whom 53 and 112, respectively, had CVEs. The IAD was calculated by dividing the area of desaturation by total sleep time in polysomnography. C-reactive protein (CRP) was also measured for all patients.
In the mild to moderate OSA patients, the mean IAD of the CVEs group was significantly higher than that of the non-CVE group (94.4 +/- 82.7 vs. 62.3 +/- 50.8, p = 0.001), whereas mean AHI and 3% oxygen desaturation index were similar in both groups. Multivariate analysis demonstrated that the IAD was an independent variable for CVEs (OR 1.006, 95% confidence interval 1.001-1.012, p = 0.031). Moreover, the IAD level of the high CRP group was significantly higher than that of the low CRP group (92.9 +/- 84.8 vs. 63.9 +/- 54.5, p = 0.009). There was no significant difference in AHI, IAD or other polysomnographic parameters in the severe OSA patients.
IAD might be superior to AHI alone in the evaluation of the history of CVEs in mild to moderate OSA patients, and it deserves attention as a possible predictor of future CVEs.
尽管阻塞性睡眠呼吸暂停(OSA)的严重程度通过呼吸暂停低通气指数(AHI)进行评估,但 AHI 在评估心血管风险方面的价值,尤其是在轻度至中度 OSA 中,尚不清楚。
本研究旨在评估一种新指数,即综合去饱和面积(IAD),在评估此类患者心血管事件(CVE)发生率方面的有效性。
我们纳入了 230 例经多导睡眠图(PSG)诊断为轻度至中度 OSA 的连续患者和 354 例重度 OSA 患者,其中分别有 53 例和 112 例患有 CVE。通过将 PSG 中的去饱和面积除以总睡眠时间来计算 IAD。所有患者均测量 C 反应蛋白(CRP)。
在轻度至中度 OSA 患者中,CVE 组的平均 IAD 明显高于非 CVE 组(94.4 +/- 82.7 与 62.3 +/- 50.8,p = 0.001),而两组的平均 AHI 和 3%氧去饱和指数相似。多变量分析表明,IAD 是 CVE 的独立变量(OR 1.006,95%置信区间 1.001-1.012,p = 0.031)。此外,高 CRP 组的 IAD 水平明显高于低 CRP 组(92.9 +/- 84.8 与 63.9 +/- 54.5,p = 0.009)。重度 OSA 患者的 AHI、IAD 或其他 PSG 参数无显著差异。
IAD 可能优于单独的 AHI,用于评估轻度至中度 OSA 患者的 CVE 病史,并且作为未来 CVE 的可能预测指标值得关注。